Life Science Investing Beam Therapeutics to Participate in Upcoming September 2025 Investor Conferences
Life Science Investing Beam Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease
Harvest Gold Provides Update on its Ongoing Drill Program at Mosseau and Has Completed its High-Resolution Airborne Magnetic Survey of Mosseau and Labelle
